LAKE OSWEGO, Oregon, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at BioX: Noble Financial Capital Markets’ Life Sciences Exposition. The presentation will take place on September 24, 2012 at 8:00 AM EDT at the University of Connecticut, Stamford Campus.
